{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:03:58Z","timestamp":1788411838131,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jaad.2021.08.067","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T14:10:16Z","timestamp":1635430216000},"page":"774-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics"],"prefix":"10.1016","volume":"89","author":[{"given":"Julia L.","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carl G.","family":"Streed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica D.","family":"Dommasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Klinton","family":"Peebles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7522","key":"10.1016\/j.jaad.2021.08.067_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jaad.2021.08.067_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0190-9622(93)70223-G","article-title":"Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects","volume":"29","author":"Cash","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0190-9622(92)70134-2","article-title":"The psychological effects of androgenetic alopecia in men","volume":"26","author":"Cash","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.08.067_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/PPA.S121218","article-title":"Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People\u2019s Republic of China","volume":"11","author":"Zhang","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaad.2021.08.067_bib5","series-title":"Understanding the Well-Being of LGBTQI+ Populations","first-page":"4","author":"Patterson","year":"2020"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psc.2016.10.005","article-title":"Hormonal and surgical treatment options for transgender men (female-to-male)","volume":"40","author":"Gorton","year":"2017","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"10.1016\/j.jaad.2021.08.067_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40257-018-0343-z","article-title":"Understanding and addressing hair disorders in transgender individuals","volume":"19","author":"Gao","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.08.067_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1529-8019.2008.00214.x","article-title":"Androgens and hair growth","volume":"21","author":"Randall","year":"2008","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2021.08.067_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.det.2019.10.010","article-title":"Androgenetic alopecia in gender minority patients","volume":"38","author":"Marks","year":"2020","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"8","key":"10.1016\/j.jaad.2021.08.067_bib12","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"5","key":"10.1016\/j.jaad.2021.08.067_bib13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/bjd.18099","article-title":"Hair loss among transgender and gender-nonbinary patients: a cross-sectional study","volume":"181","author":"Marks","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jamadermatol.2020.5475","article-title":"Incidence and factors associated with androgenetic alopecia among transgender and gender-diverse patients treated with masculinizing hormone therapy","volume":"157","author":"Thoreson","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men\u2014short version","volume":"32","author":"Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaad.2017.02.054","article-title":"The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis","volume":"77","author":"Adil","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2003.00621.x","article-title":"Hypertrichosis in females applying minoxidil topical solution and in normal controls","volume":"17","author":"Dawber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: a review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial","volume":"82","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib21","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jaad.2019.08.084","article-title":"Very-low-dose oral minoxidil in male androgenetic alopecia: a study with quantitative trichoscopic documentation","volume":"82","author":"Pirmez","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s13555-020-00448-x","article-title":"Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of male patients with androgenetic alopecia: an open-label and global photographic assessment","volume":"10","author":"Panchaprateep","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","article-title":"Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients","volume":"84","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.08.067_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2019.04.054","article-title":"Effectiveness and safety of low-dose oral minoxidil in male\u00a0androgenetic alopecia","volume":"81","author":"Jimenez-Cauhe","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.08.067_bib25","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/jdv.16616","article-title":"Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case-series of 64 patients","volume":"34","author":"Sinclair","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib26","doi-asserted-by":"crossref","first-page":"e14622","DOI":"10.1111\/dth.14622","article-title":"Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo-controlled trial","volume":"34","author":"Uzel","year":"2021","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2021.08.067_bib27","first-page":"457","article-title":"A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","volume":"17","author":"Lee","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40257-018-0387-0","article-title":"Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a\u00a0randomized, double-blind, controlled study","volume":"20","author":"Suchonwanit","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.08.067_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/ced.13184","article-title":"Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients","volume":"42","author":"Moreno-Arrones","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.08.067_bib30","first-page":"51","article-title":"Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?","volume":"7","author":"Singh","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib31","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s12020-020-02219-2","article-title":"Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function","volume":"68","author":"Pallotti","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2020.3385","article-title":"Investigation of suicidality and psychological adverse events in patients treated with finasteride","volume":"157","author":"Nguyen","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamadermatol.2020.3384","article-title":"Ongoing concerns regarding finasteride for the treatment of male-pattern androgenetic alopecia","volume":"157","author":"Ho","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib34","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.08.067_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/CIA.S192435","article-title":"The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","article-title":"Spironolactone for treatment of female pattern hair loss","volume":"83","author":"Burns","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.08.067_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000509001","article-title":"Examining the safety and efficacy of low-level laser therapy for male and female pattern hair loss: a review of the literature","volume":"6","author":"Egger","year":"2020","journal-title":"Skin Appendage Disord"},{"issue":"2","key":"10.1016\/j.jaad.2021.08.067_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.08.067_bib40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/lsm.22684","article-title":"Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: a randomized controlled study","volume":"49","author":"Esmat","year":"2017","journal-title":"Lasers Surg Med"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib41","doi-asserted-by":"crossref","first-page":"e13835","DOI":"10.1111\/dth.13835","article-title":"A systematic review of the effect of platelet-rich plasma on androgenetic alopecia of women","volume":"33","author":"Torabi","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09546634.2016.1179712","article-title":"Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia","volume":"28","author":"Gupta","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijwd.2018.08.004","article-title":"Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol","volume":"5","author":"Stevens","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.08.067_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40261-019-00806-4","article-title":"Efficacy of platelet-rich plasma for treating androgenic alopecia of varying grades","volume":"39","author":"Qu","year":"2019","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/ijt.ijt_75_16","article-title":"A comparative study\u00a0of microneedling with platelet-rich plasma plus topical\u00a0minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia","volume":"9","author":"Shah","year":"2017","journal-title":"Int J Trichology"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.fsc.2013.05.007","article-title":"Hairline lowering","volume":"21","author":"Kabaker","year":"2013","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib47","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/lary.28370","article-title":"Scalp advancement for transgender women: closing the gap","volume":"130","author":"Garcia-Rodriguez","year":"2020","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib48","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PRS.0000000000003149","article-title":"Facial feminization surgery: simultaneous hair transplant during forehead reconstruction","volume":"139","author":"Capit\u00e1n","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.jaad.2021.08.067_bib49","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00042728-200510000-00002","article-title":"Effects of finasteride (1 mg) on hair transplant","volume":"31","author":"Leavitt","year":"2005","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2021.08.067_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fsc.2013.04.004","article-title":"Patient selection, candidacy, and treatment planning for hair restoration surgery","volume":"21","author":"Konior","year":"2013","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaad.2020.08.124","article-title":"Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss","volume":"84","author":"Jimenez-Cauhe","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.08.067_bib52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1517\/14740338.2012.712109","article-title":"Drug-induced gynecomastia: an\u00a0evidence-based review","volume":"11","author":"Deepinder","year":"2012","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijwd.2016.11.007","article-title":"Dermatologic care of the transgender patient","volume":"3","author":"Ginsberg","year":"2017","journal-title":"Int J Women's Dermatol"},{"key":"10.1016\/j.jaad.2021.08.067_bib54","unstructured":"PROPECIA (finasteride) tablets, 1 mg drug insert. D. Merck Inc; 2010."},{"issue":"5","key":"10.1016\/j.jaad.2021.08.067_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/09546634.2018.1528327","article-title":"Shedding light on the FDA\u2032s 510 (k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia","volume":"30","author":"Wang","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2021.08.067_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2006.12.029","article-title":"A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification","volume":"57","author":"Lee","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.08.067_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1524-4725.2000.00009.x","article-title":"Multifactorial classification of male and female\u00a0androgenetic alopecia","volume":"26","author":"Bouhanna","year":"2000","journal-title":"Dermatol Surg"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221025743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221025743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:27:50Z","timestamp":1759274870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221025743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0190962221025743"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.08.067","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.08.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}